Learn about Cannabinol, CBN, Rare Cannabinoids, EB, Glaucoma

Skip to content

Pharmaceutical
Investors
Corporate
Learn

Pharmaceutical
Investors
Corporate
Learn

Latest Events

Life Sciences Virtual Investor Forum

Date: December 11, 2025

Add to Calendar

InMed Presenting at Life Sciences Investor Forum

Date: September 18, 2025

Time: 2:00pm ET

Add to Calendar

H.C. Wainwright 27th Annual Global Investment Conference

Date: September 8-10, 2024

Add to Calendar

Alzheimer’s Association International Conference 2025

Date: July 27-31, 2025

Add to Calendar

InMed’s CEO, Eric A. Adams, at J.P. Morgan Healthcare Conference

Date: Jan 13-16, 2025

Fierce Biotech Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step

Date: November 12, 2024

Time: 2:00pm ET

Add to Calendar

Management

Board of Directors

Scientific Advisory Board

Investor Alerts

Sign up to receive news releases from InMed Pharmaceuticals.

#1445 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

INM-901 for Alzheimer’s Disease
INM-089 for Age-related Macular Degeneration
INM-755 for Epidermolysis Bullosa

Investor

News
Events
Stock Information
Corporate Governance
Financials & AGM Materials
Filings
Presentations
Media & Videos
Investor Contact

CORPORATE

Management
Board of Directors
Scientific Advisors
Partners and Collaborators
Careers
Contact

Learn

Articles and Videos
Webinar: Alzheimer’s Outlook – Neuroinflammation, the Next Step
The Evolving Alzheimer’s Disease Landscape

© Copyright 2026 InMed Pharmaceuticals Inc.

Privacy Policy
Terms of Use
Legal Disclaimer

Find Us On:

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*

First name* Last name*

Email*

Consent*

By providing your e-mail address, you consent to receive news, press releases, quarterly and annual reports, presentations and other information from InMed Pharmaceuticals Inc. You can unsubscribe at any time.

CAPTCHA